Take with meals for better comfort
In mid-2024, the Endocrine Society warned that online prescribing of compounded GLP-1s poses patient safety risks and undermines public confidence in obesity care. The organization called for stricter verification of clinicians and for oversight of digital compounding networks that have limited traceability or pharmacovigilance. Their concern echoed that of the FDA , which, after investigating multiple adverse-event reports linked to unapproved semaglutide, issued formal warnings to both compounders and telehealth distributors
Ive lost 20 pounds so far and feel much better, both mentally and physically
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may have a welcome benefit in addition to weight loss and glycemic control, with new data presented at ObesityWeek, the annual meeting of the Obesity Society, showing that use of these medications is associated with a reduction in problematic alcohol use
A relaxing, painless procedure with no downtime
It has no approved drug application